Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptides-Reference-Cited by-同舟云学术

Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptides

Published:2003-02 Issue:2 Volume:64 Page:245-255
ISSN:0198-8859
Container-title:Human Immunology
language:en
Short-container-title:Human Immunology

Author:

Kessler Jan H,Mommaas Bregje,Mutis Tuna,Huijbers Ivo,Vissers Debby,Benckhuijsen Willemien E,Schreuder Geziena M.Th,Offringa Rienk,Goulmy Els,Melief Cornelis J.M,van der Burg Sjoerd H,Drijfhout Jan W

Publisher

Elsevier BV

Subject

General Medicine,Immunology,Immunology and Allergy

Reference50 articles.

1. Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase;van der Burg;AIDS,1995

2. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif;Cerny;J Clin Invest,1995

3. Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans;Geluk;J Immunol,2000

4. Efficient identification of novel HLA-A(*)0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis;Kessler;J Exp Med,2001

5. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens;Bjorkman;Nature,1987

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BMX-A and BMX-S: Accessible cell-free methods to estimate peptide-MHC-I affinity and stability;Molecular Immunology;2023-09

2. Personalized neoantigen viro-immunotherapy platform for triple-negative breast cancer;Journal for ImmunoTherapy of Cancer;2023-08

3. Predicting Peptide HLA-II Presentation Using Immunopeptidomics, Transcriptomics and Deep Multimodal Learning;2022-09-22

4. CD8 T cell function and cross-reactivity explored by stepwise increased peptide-HLA versus TCR affinity;Frontiers in Immunology;2022-08-10

5. Optimized Anchor-Modified Peptides Targeting Mutated RAS Are Promising Candidates for Immunotherapy;Frontiers in Immunology;2022-05-26